How has Balchem's estimated share-based compensation expense changed year-over-year?

Balchem's estimated share-based compensation expense increased by 15.5% year-over-year, from $16.86M to $19.47M.

Balchem BCPC Estimated share-based compensation expense

Revenue$270.7M+8.1%

Gross profit$101.1M+14.6%

Operating income$55.6M+9.0%

Net income$40.3M+8.7%

EPS (diluted)$1.25+10.6%

Cash & equivalents$72.9M+46.0%

Total debt$37.4M-1.7%

Total equity$1.3B+6.3%

Total assets$1.7B+4.7%

Operating cash flow$40.1M+9.9%

Market cap$5.33B+0.5%

Enterprise value$5.3B+0.1%

P/E33.7×-5.1×

P/S5×-0.5×

Gross margin36.3%+0.7pp

Operating margin20.2%+0.3pp

Net margin15%+0.8pp

FCF margin14.9%—

Return on equity12.7%+0.7pp

Debt / equity0×0.0×

Current ratio2.5×+0.1×

Reported directly by Balchem in its filing.

Tagged under the XBRL concept bcpc:EstimatedShareBasedCompensationExpenseRemainderOfFiscalYear.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Balchem's estimated share-based compensation expense?: Balchem (BCPC) reported estimated share-based compensation expense of $19.47M in Q1 2026.
How has Balchem's estimated share-based compensation expense changed year-over-year?: Balchem's estimated share-based compensation expense increased by 15.5% year-over-year, from $16.86M to $19.47M.